Terms: = Sarcomas AND DUX4L1, DUX4, P0CJ90, P0CJ89, P0CJ88, P0CJ86, P0CJ85, 22947
115 results:
1. Spontaneous expression of the CIC::dux4 fusion oncoprotein from a conditional allele potently drives sarcoma formation in genetically engineered mice.
Hendrickson PG; Oristian KM; Browne MR; Luo L; Ma Y; Cardona DM; Nash JO; Ballester PL; Davidson S; Shlien A; Linardic CM; Kirsch DG
Oncogene; 2024 Apr; 43(16):1223-1230. PubMed ID: 38413794
[TBL] [Abstract] [Full Text] [Related]
2. Machine Learning-Supported Diagnosis of Small Blue Round Cell sarcomas Using Targeted RNA Sequencing.
Schlieben LD; Carta MG; Moskalev EA; Stöhr R; Metzler M; Besendörfer M; Meidenbauer N; Semrau S; Janka R; Grützmann R; Wiemann S; Hartmann A; Agaimy A; Haller F; Ferrazzi F
J Mol Diagn; 2024 May; 26(5):387-398. PubMed ID: 38395409
[TBL] [Abstract] [Full Text] [Related]
3. CIC-Rearranged Sarcoma.
Makise N; Yoshida A
Surg Pathol Clin; 2024 Mar; 17(1):141-151. PubMed ID: 38278603
[TBL] [Abstract] [Full Text] [Related]
4. KDM2B-Rearranged Soft Tissue sarcomas Expand the Concept of BCOR-Associated Sarcoma.
Motoi T; Hirata M; Kukita Y; Satomi K; Tamura H; Adachi S; Matsushita Y; Horiguchi SI; Hishima T; Ikegami M; Okuma T; Tao K; Arakawa A; Ogawa C; Matsuda K; Ichimura K; Nakamura H; Mori T; Yoshida A
Mod Pathol; 2023 Nov; 36(11):100317. PubMed ID: 37634866
[TBL] [Abstract] [Full Text] [Related]
5. Clinical characteristics and outcomes for children, adolescents and young adults with "CIC-fused" or "BCOR-rearranged" soft tissue sarcomas: A multi-institutional European retrospective analysis.
Sparber-Sauer M; Corradini N; Affinita MC; Milano GM; Pierron G; Carton M; Tirode F; Pissaloux D; Alaggio R; Vokuhl C; Bisogno G; Berlanga P; Ferrari A; Orbach D
Cancer Med; 2023 Jul; 12(13):14346-14359. PubMed ID: 37212486
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological features of five cases of CIC::dux4 positive sarcomas, including literature review.
Rekhi B; Rumdee R; Shetty O
Ann Diagn Pathol; 2023 Aug; 65():152153. PubMed ID: 37167753
[TBL] [Abstract] [Full Text] [Related]
7. CIC-rearranged sarcoma presenting with superior vena cava syndrome: case report.
Ascione A; Martino G; Di Donato F; Casini B; Covello R; Ascani S
Pathologica; 2023 Apr; 115(2):97-100. PubMed ID: 37114626
[TBL] [Abstract] [Full Text] [Related]
8. Human dux4 and mouse Dux interact with STAT1 and broadly inhibit interferon-stimulated gene induction.
Spens AE; Sutliff NA; Bennett SR; Campbell AE; Tapscott SJ
Elife; 2023 Apr; 12():. PubMed ID: 37092726
[TBL] [Abstract] [Full Text] [Related]
9. Subtype-selective induction of apoptosis in translocation-related sarcoma cells induced by PUMA and BIM upon treatment with pan-PI3K inhibitors.
Isoyama S; Tamaki N; Noguchi Y; Okamura M; Yoshimatsu Y; Kondo T; Suzuki T; Yaguchi SI; Dan S
Cell Death Dis; 2023 Feb; 14(2):169. PubMed ID: 36849535
[TBL] [Abstract] [Full Text] [Related]
10. A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl).
Palmerini E; Gambarotti M; Italiano A; Nathenson MJ; Ratan R; Dileo P; Provenzano S; Jones RL; DuBois SG; Martin-Broto J; de Alava E; Baldi GG; Grignani G; Ferraresi V; Brunello A; Paoluzzi L; Bertulli R; Hindi N; Montemurro M; Rothermundt C; Cocchi S; Salguero-Aranda C; Donati D; Martin JD; Abdelhamid Ahmed AH; Mazzocca A; Carretta E; Cesari M; Pierini M; Righi A; Sbaraglia M; Laginestra MA; Scotlandi K; Dei Tos AP; Ibrahim T; Stacchiotti S; Vincenzi B
Eur J Cancer; 2023 Apr; 183():11-23. PubMed ID: 36791667
[TBL] [Abstract] [Full Text] [Related]
11. Expanding the Molecular Diversity of CIC-Rearranged sarcomas With Novel and Very Rare Partners.
Linos K; Dermawan JK; Bale T; Rosenblum MK; Singer S; Tap W; Dickson MA; Hornick JL; Antonescu CR
Mod Pathol; 2023 May; 36(5):100103. PubMed ID: 36788092
[TBL] [Abstract] [Full Text] [Related]
12. Chromosome Translocation t(10;19)(q26;q13) in a CIC-sarcoma.
Panagopoulos I; Andersen K; Gorunova L; Hognestad HR; Pedersen TD; Lobmaier I; Micci F; Heim S
In Vivo; 2023; 37(1):57-69. PubMed ID: 36593014
[TBL] [Abstract] [Full Text] [Related]
13. Patterns of care and outcome of CIC-rearranged sarcoma patients: A nationwide study of the French sarcoma group.
Brahmi M; Gaspar N; Gantzer J; Toulmonde M; Boudou-Rouquette P; Bompas E; Firmin N; Valentin T; Cancel M; Duffaud F; Bertucci F; Perrin C; Dufresne A; Marec-Bérard P; Jean-Denis M; Ray-Coquard I; Le Loarer F; Pierron G; Tirode F; Blay JY; Watson S
Cancer Med; 2023 Apr; 12(7):7801-7807. PubMed ID: 36537582
[TBL] [Abstract] [Full Text] [Related]
14. A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results.
Attia S; Bolejack V; Ganjoo KN; George S; Agulnik M; Rushing D; Loggers ET; Livingston MB; Wright J; Chawla SP; Okuno SH; Reinke DK; Riedel RF; Davis LE; Ryan CW; Maki RG
Cancer Med; 2023 Jan; 12(2):1532-1539. PubMed ID: 35950293
[TBL] [Abstract] [Full Text] [Related]
15. CIC-dux4 sarcomas.
Brahmi M; Vanacker H; Macagno N; Tirode F; Dufresne A
Curr Opin Oncol; 2022 Jul; 34(4):342-347. PubMed ID: 35730520
[TBL] [Abstract] [Full Text] [Related]
16. Central nervous system sarcoma with ATXN1::dux4 fusion expands the concept of CIC-rearranged sarcoma.
Satomi K; Ohno M; Kubo T; Honda-Kitahara M; Matsushita Y; Ichimura K; Narita Y; Ichikawa H; Yoshida A
Genes Chromosomes Cancer; 2022 Nov; 61(11):683-688. PubMed ID: 35715887
[TBL] [Abstract] [Full Text] [Related]
17. Ewing sarcoma and related FET family translocation-associated round cell tumors: A century of clinical and scientific progress.
Maki RG; Grohar PJ; Antonescu CR
Genes Chromosomes Cancer; 2022 Aug; 61(8):509-517. PubMed ID: 35443099
[TBL] [Abstract] [Full Text] [Related]
18. Co-expression of ERG and CD31 in a subset of CIC-rearranged sarcoma: a potential diagnostic pitfall.
Kojima N; Arai Y; Satomi K; Kubo T; Matsushita Y; Mori T; Matsushita H; Ushijima T; Yatabe Y; Shibata T; Yonemori K; Ichimura K; Ichikawa H; Kawai A; Yoshida A
Mod Pathol; 2022 Oct; 35(10):1439-1448. PubMed ID: 35440765
[TBL] [Abstract] [Full Text] [Related]
19. WEE1 kinase is a therapeutic vulnerability in CIC-dux4 undifferentiated sarcoma.
Ponce RKM; Thomas NJ; Bui NQ; Kondo T; Okimoto RA
JCI Insight; 2022 Mar; 7(6):. PubMed ID: 35315355
[TBL] [Abstract] [Full Text] [Related]
20. Systemic treatments and outcomes in CIC-rearranged Sarcoma: A national multi-centre clinicopathological series and literature review.
Connolly EA; Bhadri VA; Wake J; Ingley KM; Lewin J; Bae S; Wong DD; Long AP; Pryor D; Thompson SR; Strach MC; Grimison PS; Mahar A; Bonar F; Maclean F; Hong A
Cancer Med; 2022 Apr; 11(8):1805-1816. PubMed ID: 35178869
[TBL] [Abstract] [Full Text] [Related]
[Next]
